Bevaro 400 mg Injection
  1. Home
  2. Pharma Products
  3. Cadila Pharmaceutical Ltd
  4. Bevaro 400 mg Injection

Bevaro 400 mg Injection

Bevaro 400 mg Injection contains bevacizumab, a monoclonal antibody used in the treatment of several types of cancer. It is supplied as a 400 mg/16 mL injection and is administered by intravenous infusion under medical supervision. Bevacizumab blocks VEGF, helping reduce the formation of blood vessels that support tumor growth.

BUY NOW

Category

Bevaro 400 mg Injection is used with other anticancer medicines for conditions such as colorectal cancer, non-small cell lung cancer, kidney cancer, cervical cancer, and selected ovarian cancers. Bevacizumab targets vascular endothelial growth factor, a protein involved in the formation of new blood vessels around tumors. By inhibiting VEGF activity, it can reduce the blood supply available to growing cancer cells. Treatment is given according to the prescribed oncology protocol, with monitoring for blood pressure changes, bleeding, infusion reactions, and other treatment-related effects.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 400 mg
Concentration 400 mg/16 mL
Dosage Form Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial

Product Also Known As

Bevaro 400 mg Injection, Bevaro 400 Injection, Bevaro Bevacizumab Injection, Bevacizumab 400 mg Injection, Bevacizumab 400 mg/16 mL Injection, Bevacizumab Cancer Injection